Questions with no answer at all. Not questions with no accepted answer — those are elsewhere.
Setup, so nobody has to ask: ALT · AST · ecnoglutide. Both of these get recommended confidently by different people, which suggests neither is obviously right. My…
What I am working with: SOUL · 15 mg. I would like help reading this properly rather than being told what conclusion to reach. I have the full report including the…
Numbers first: 99.4% · lot-specific certificate. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
What I have: ATTAIN-1 · hair thinning · 50 mg. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
For reference: QYB · QST · Spain. I am trying to choose between two options that are usually discussed as though only one exists. I am not optimising for price, but I…
Setup, so nobody has to ask: PIONEER-1 · mazdutide. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary sources all…
Stated plainly: dulaglutide · 2–8 °C · forty-two days. I am trying to build something sustainable rather than something thorough that I will abandon. I have already…
The specifics, since they change the answer: 98.8% · PeptideMeter · 98.4%. An unexpected observation, and I would like a differential rather than reassurance. The…
What I am working with: 8 units · 8 mg/mL. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the theory. What I…
Stated plainly: retatrutide · 5 mg/mL. I have worked this out and I would like someone to find the error, because I suspect there is one. My working so far, for the…
Setup, so nobody has to ask: 0.9% sodium chloride · fourteen days. This is a procedural question rather than a theoretical one, and I would like the procedure rather…
Details up front: a TFA mobile phase · dulaglutide · a C4 column. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have…
What I have: STEP 3 · dulaglutide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
Details up front: cagrilintide · 0.9% sodium chloride. I would like to understand the steps well enough to explain them to someone else. I have access to a…
The case in front of me: 40 mg · 2 mL · 0.9% sodium chloride. I want the working, not the result — I need to be able to redo it with different numbers. I care about…
Conditions: FLOW · liraglutide. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and monographs without…
Setup, so nobody has to ask: creatinine · cystatin C · semaglutide. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume…
Numbers first: Medutest · Janoshik · tirzepatide. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
Concretely: survodutide · twenty-eight days. I have done this once and I suspect I got away with it rather than got it right. For context: I keep records of every…
The case in front of me: CPC · Sangon Biotech (Shanghai). I would like the axes of comparison first and the recommendation second. I have tried the first option and…
For reference: AST · semaglutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping rules, not…
I have both a purity figure and a content figure, which is why the discrepancy is visible. This is presented as though it settles something, and I am not convinced it…
Numbers first: SGN · Nantong · Australia. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work…
Details up front: KP · dulaglutide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…